Polymorphism in drug design and delivery
Bernstein, J.
Progress in Clinical and Biological Research 289: 203-215
1989
ISSN/ISBN: 0361-7742 PMID: 2657749 Document Number: 345849
Document emailed within 1 workday
Related Documents
Csaba, N.; Alonso, M.J. 2014: 12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) Journal of Controlled Release: Official Journal of the Controlled Release Society 190: 53-54Christie, R.J.; Findley, D.J.; Grainger, D.W. 2004: Design and synthesis of a new polymer drug delivery conjugate Biomedical Sciences Instrumentation 40: 136-141
Zhang, J.-y.; Zhao, Y.-j.; Yang, X.-l. 2006: Design and manufacture of microneedles array for transdermal drug delivery Zhongguo Yi Liao Qi Xie Za Zhi 30(1): 33-38
Tsunoda, S.; Tsutsumi, Y.; Mayumi, T. 1998: Molecular design of polymer-conjugated cytokines and its application for drug delivery systems Nihon Rinsho. Japanese Journal of Clinical Medicine 56(3): 573-578
Meka, V.S.; Songa, A.S.; Nali, S.R.; Battu, J.R.; Kolapalli, V.R.M. 2012: Design and in vitro evaluation of effervescent gastric floating drug delivery systems of propanolol HCl Investigacion Clinica 53(1): 60-70
Pfister, W.R.; Hsieh, D.S. 1990: Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations Medical Device Technology 1(6): 28-33
Tamilvanan, S.; Venkatesh Babu, R.; Kannan, K.; Basu, S.K.; Sa, B. 2008: Manufacturing techniques and excipients used during the design of biodegradable polymer-based microspheres containing therapeutic peptide/protein for parenteral controlled drug delivery PDA Journal of Pharmaceutical Science and Technology 62(2): 125-154
Gerrard, S.E.; Baniecki, M.L.; Sokal, D.C.; Morris, M.K.; Urdaneta-Hartmann, S.; Krebs, F.C.; Wigdahl, B.; Abrams, B.F.; Hanson, C.V.; Slater, N.K.H.; Edwards, A.D. 2012: A nipple shield delivery system for oral drug delivery to breastfeeding infants: microbicide delivery to inactivate HIV International Journal of Pharmaceutics 434(1-2): 224-234
Masters, D.B. 2002: Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices Official Gazette of the United States Patent and Trademark Office Patents 1254(5)
Stack 1996: Local Drug Delivery: the Development of a Drug Delivery Stent Journal of Invasive Cardiology 8(8): 396-397
Jenke, D. 2010: Application of Quality by Design (QbD) Principles to Extractables/Leachables Assessment. Establishing a Design Space for Terminally Sterilized Aqueous Drug Products Stored in a Plastic Packaging System PDA Journal of Pharmaceutical Science and Technology 64(6): 527-535
Benghuzzi, H.A.; England, B.G.; Bajpai, P.K. 1992: Characterization of ceramic drug delivery devices: the effect of various temperature of incubation on the delivery of biologicals Biomedical Sciences Instrumentation 28: 129-134
Benghuzzi, H.A.; England, B.G.; Bajpai, P.K. 1991: In vivo delivery of estradiol from ceramic drug delivery devices Biomedical Sciences Instrumentation 27: 181-187
Kantor, R.; Katzenstein, D. 2003: Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution Aids Reviews 5(1): 25-35
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Kutter, E.; Austel, V. 1981: Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS Arzneimittel-Forschung 31(1a): 135-141
Guo, Z.-r. 2008: Strategy of molecular drug design: hits, leads and drug candidates Yao Xue Xue Bao 43(9): 898-904
Luna, D.; Otero, C.; Risk, M.; Stanziola, E.; González Bernaldo de Quirós, Fán. 2016: Impact of Participatory Design for Drug-Drug Interaction Alerts. A Comparison Study Between Two Interfaces Studies in Health Technology and Informatics 228: 68-72
Luna, D.R.; Rizzato Lede, D.A.; Rubin, L.; Otero, C.M.; Ortiz, J.M.; García, Mónica.G.; Rapisarda, R.P.; Risk, M.R.; González Bernaldo de Quirós, Fán. 2017: User-Centered Design Improves the Usability of Drug-Drug Interaction Alerts: A Validation Study in the Real Scenario Studies in Health Technology and Informatics 245: 1085-1089